| Model Number |
40021 |
| Medical Device Problem Code |
Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Codes |
Anemia (1706); Hematoma (1884); Hemorrhage/Blood Loss/Bleeding (1888)
|
| Date of Event |
06/28/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that the same day post implant of this 21mm aortic bioprosthetic valve, it was reported that the patient had coagulopathy and hemodynamic instability, requiring medication and transfusions of 4 units packed red blood cells (prbc), 4 units fresh frozen plasma (ffp), 3 packs platelets and 4 units cryoprecipitate.The patient was then brought back to the operating room for concern of tamponade, however tamponade was not present.A hematoma was evacuated and the patient stabilized.No additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|